Emerging plasmid-encoded colistin resistance: the animal world as the culprit?

作者
Laurent Poirel,Patrice Nordmann
出处
期刊:Journal of Antimicrobial Chemotherapy [Oxford University Press]
卷期号:71 (8): 2326-2327 被引量:81
标识
DOI:10.1093/jac/dkw074
摘要

Sir, A recent study from China identified transferable polymyxin resistance in Gram-negative bacilli from human and animal isolates.1 Although polymyxins, including colistin and polymyxin B, were among the very few antibiotics for which no transferable resistance had been identified, we are now facing a novel threat with the identification of a plasmid-encoded resistance mechanism. Colistin is an old drug that was first introduced in 1959 but remained on the shelf for many years due to renal and neurotoxicity.2 However, we are experiencing a renewed interest in this drug due to the rapid emergence of MDR Gram-negative organisms. The plasmid-borne mcr-1 gene encodes a phosphoethanolamine transferase that mediates addition of phosphoethanolamine to the lipid A moiety of the lipopolysaccharide, consequently conferring resistance to polymyxins.1 This gene has thus far mainly been found in Escherichia coli, and to a lesser extent in Klebsiella spp. and Salmonella spp. Very shortly after the original report, other studies reported identification of the mcr-1 gene in human E. coli isolates in many different countries, including in Algeria, Denmark, France, Germany, Laos, the Netherlands, Malaysia, Nigeria, Switzerland and Thailand.3–5 It was also identified from imported food products in Denmark (meat) and Switzerland (vegetables).6,7 In addition, plasmid-encoded carbapenem and colistin resistance may be co-associated in E. coli.3,5,8 In addition, positive Salmonella enterica isolates of different serotypes were identified from food samples in Portugal in 2011, and France in 2012 and 2013.9,10 Finally, an epidemiological survey conducted in France on a collection of ESBL-producing E. coli isolates (n = 517) recovered from the faeces of diarrheic veal calves on farms from 2005 to 2014 showed a very high rate of MCR-1-positive isolates (20.5%).11 Taken together, these findings indicate that: (i) the spread of mcr-1 is not recent, as it has already occurred worldwide, probably due to its location on conjugative plasmids; and (ii) E. coli is so far the main reservoir of this resistance trait among human, animal and environmental isolates. This is a source of concern since E. coli isolates are easily exchanged from the environment to humans in which they may remain as a commensal in the gut flora; in addition, E. coli is the number one pathogen for humans. MCR-1 is one of the few and clear examples of the animal origin of a resistance trait that may later hit the entire human health system, along with the examples of some MRSA clones (such as CC398), the serotype O104:H4 CTX-M-15 ESBL-producing enteroaggregative E. coli and ESBL-producing Salmonella spp. strains. The animal origin of MCR-1 is sustained by: (i) the number of reports of animal isolates expressing mcr-1, which is already high; and (ii) heavy usage of colistin in veterinary medicine. By standardizing the sales of antimicrobials in relation to the total weight of animals ‘at risk’ undergoing treatment across Europe in 2011, it was estimated that polymyxins are the fifth most sold group of antimicrobials (7%).12 In Europe, colistin and polymyxin B are used for treating infections caused by Enterobacteriaceae in rabbits, broilers, veal, beef cattle, dairy cattle and (primarily) pigs. In addition, in other parts of the world, polymyxins are used as growth promoters, a usage that has been banned in Europe since 2006. The animal origin of MCR-1 is also sustained by the genetics associated with the mcr-1 gene. When investigating the mcr-1-positive E. coli KRI recovered from the urine of a community patient in Switzerland,3 an insertion sequence (ISApl1) was identified upstream of the mcr-1 gene that was 100% identical to one identified in Pasteurella multocida, which is a common animal pathogen, in particular for pigs. In addition, this same E. coli co-expressed the broad-spectrum β-lactamase gene blaCMY-2, and the florfenicol resistance gene floR, both genes that are widely disseminated in animal isolates, with florfenicol being used in veterinary medicine only. It seems very likely that the occurrence of polymyxin resistance in animal isolates has been underestimated and unrecognized for years, since the determination of polymyxin susceptibility is difficult. Disc diffusion and Etest are not reliable techniques, and broth microdilution is the gold standard technique but it is cumbersome and not used on a regular basis, in particular in veterinary medicine. Therefore, there is an urgent need for rapid diagnostic tests for polymyxin resistance in Enterobacteriaceae. The impact of the use of polymyxins in agriculture was not seriously taken into account as long as there was no critical need for colistin in human medicine. However, times have changed and a co-ordinated re-evaluation of polymyxin usage in agriculture is urgently needed to prevent selection in veterinary medicine of polymyxin-resistant isolates that might subsequently be transferred to humans. Similarly, using polymyxins in selective digestive decontamination to prevent the spread of MDR bacteria in hospitals should be discouraged. Nevertheless, a decision to ban polymyxins in agriculture would be far from simple and might be a matter of balancing risk against benefits. In a recent review debating the use of colistin-containing products within the European Union and European Economic Area, Catry et al.12 concluded by stating ‘Should colistin resistance determinants be found on mobile genetic elements in bacteria of concern from human or animal origin, or should a clonal expansion of pathogenic polymyxin-resistant bacteria take place, further risk profiling would be required’. Here we are, unfortunately! This work was funded by the University of Fribourg, Switzerland. None to declare.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
蜀勤完成签到,获得积分10
1秒前
研友_LJGmvn发布了新的文献求助10
1秒前
甜甜元蝶的应助被suiyi采纳,获得10
1秒前
孤独丹秋完成签到,获得积分10
2秒前
3秒前
3秒前
雪碧和果冻完成签到,获得积分10
3秒前
星河完成签到 ,获得积分10
3秒前
听汐完成签到 ,获得积分10
4秒前
Zhao完成签到,获得积分10
4秒前
4秒前
ace完成签到,获得积分10
4秒前
lay完成签到,获得积分10
4秒前
欢呼以柳完成签到,获得积分10
5秒前
Nobody完成签到,获得积分10
5秒前
听话的八宝粥完成签到 ,获得积分10
6秒前
6秒前
睡觉多会瞌睡完成签到,获得积分10
6秒前
6秒前
vivi完成签到,获得积分10
7秒前
leileilei完成签到,获得积分10
7秒前
suiyi完成签到,获得积分10
7秒前
星期六睡觉完成签到,获得积分10
7秒前
七色光完成签到,获得积分10
8秒前
jokerli完成签到,获得积分10
8秒前
研友_LJGmvn完成签到,获得积分10
8秒前
8秒前
活泼冬菱完成签到,获得积分10
8秒前
慕昊强完成签到,获得积分10
8秒前
月光盏完成签到,获得积分10
9秒前
尊敬背包完成签到,获得积分10
9秒前
9秒前
zxp完成签到,获得积分10
9秒前
1Arendelle1完成签到,获得积分10
10秒前
清爽的孤丝完成签到,获得积分10
11秒前
Jasper的应助被酷酷柚子采纳,获得10
11秒前
wang完成签到 ,获得积分10
11秒前
dxt完成签到,获得积分10
11秒前
董晓诗完成签到 ,获得积分10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173474
求助须知:如何正确求助?哪些是违规求助? 9565719
关于积分的说明 21781727
捐赠科研通 7767700
什么是DOI,文献DOI怎么找? 3431597
关于科研通互助平台的介绍 2555855
邀请新用户注册赠送积分活动 2476832